What was Inventiva SA’s price range in the past 12 months?
Inventiva SA lowest share price was €1.92 and its highest was €4.75 in the past 12 months.
What is Inventiva SA’s market cap?
Currently, no data Available
When is Inventiva SA’s upcoming earnings report date?
Inventiva SA’s upcoming earnings report date is Sep 25, 2024 which is in 153 days.
How were Inventiva SA’s earnings last quarter?
Inventiva SA released its earnings results on Mar 27, 2024. The company reported -€0.59 earnings per share for the quarter, beating the consensus estimate of -€0.634 by €0.044.
How many shares outstanding does Inventiva SA have?
Inventiva SA has 52,477,190 shares outstanding.
What happened to Inventiva SA’s price movement after its last earnings report?
Inventiva SA reported an EPS of -€0.59 in its last earnings report, beating expectations of -€0.634. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Inventiva SA?
Currently, no hedge funds are holding shares in GB:0RNK
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis and rare diseases. All the company's operations are located in France.